Hologic(HOLX)

Search documents
Here's Why Hologic (HOLX) is a Strong Momentum Stock
ZACKS· 2025-02-06 15:51
Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies, including daily updates, research reports, and stock screens [1][2] Zacks Style Scores - Zacks Style Scores are indicators that rate stocks based on value, growth, and momentum characteristics, helping investors identify stocks likely to outperform the market in the short term [2][3] - Each stock is rated from A to F, with A indicating the highest potential for outperformance [3] Value Score - The Value Score identifies attractive and discounted stocks using financial ratios such as P/E, PEG, and Price/Sales [3] Growth Score - The Growth Score focuses on a company's financial health and future outlook, analyzing projected and historical earnings, sales, and cash flow [4] Momentum Score - The Momentum Score helps investors capitalize on price trends by analyzing short-term price changes and earnings estimate revisions [5] VGM Score - The VGM Score combines all three Style Scores, providing a comprehensive indicator for investors seeking stocks with strong value, growth, and momentum [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to guide investors in building successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically achieved an average annual return of +25.41% since 1988, significantly outperforming the S&P 500 [8] Stock Selection Strategy - To maximize returns, investors should focus on stocks with a Zacks Rank of 1 or 2 and Style Scores of A or B [9] - Stocks with lower ranks but high Style Scores may still face downward price pressure due to negative earnings outlooks [10] Company Spotlight: Hologic Inc. (HOLX) - Hologic Inc. is a medical technology company focused on women's health, currently holding a Zacks Rank of 3 (Hold) and a VGM Score of B [11] - The company has seen upward revisions in earnings estimates, with the Zacks Consensus Estimate for fiscal 2025 at $4.28 per share, and an average earnings surprise of 2.5% [12]
Hologic(HOLX) - 2025 Q1 - Quarterly Report
2025-02-06 13:42
Washington, D.C. 20549 __________________________________________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 28, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 __________________________________________________________ HO ...
Hologic Q1 Earnings Beat, Stock Falls on Dismal '25 Sales Guidance
ZACKS· 2025-02-06 13:26
Hologic, Inc. (HOLX) reported adjusted earnings per share (EPS) of $1.03 in the first quarter of fiscal 2025, up 5.1% year over year. The metric surpassed the Zacks Consensus Estimate by 0.9%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.The adjustments include charges and benefits related to the amortization of acquired intangible assets, restructuring and integration/consolidation costs and many others. The company’s GAAP EPS was 87 cents in the quarter compared with $1.03 in the ...
Hologic(HOLX) - 2025 Q1 - Earnings Call Transcript
2025-02-06 03:06
Hologic, Inc. (NASDAQ:HOLX) Q1 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Mike Watts - Corporate Vice President, IR Steve MacMillan - Chairman, President and CEO Essex Mitchell - COO Karleen Oberton - CFO Conference Call Participants Patrick Donnelly - Citi Anthony Petrone - Mizuho Group Doug Schenkel - Wolfe Research Vijay Kumar - Evercore ISI Tycho Peterson - Jefferies Casey Woodring - JP Morgan Tejas Savant - Morgan Stanley Ryan Zimmerman - BTIG Jack Meehan - Nephron R ...
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics
ZACKS· 2025-02-05 23:30
Hologic (HOLX) reported $1.02 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 0.9%. EPS of $1.03 for the same period compares to $0.98 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $1.02 billion, representing no surprise. The company delivered an EPS surprise of +0.98%, with the consensus EPS estimate being $1.02.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they comp ...
Hologic (HOLX) Q1 Earnings Surpass Estimates
ZACKS· 2025-02-05 23:16
Hologic (HOLX) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.98 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 0.98%. A quarter ago, it was expected that this medical device maker would post earnings of $1.02 per share when it actually produced earnings of $1.01, delivering a surprise of -0.98%.Over the last four quarters, the comp ...
Hologic(HOLX) - 2025 Q1 - Quarterly Results
2025-02-05 21:01
Financial Performance - Revenue increased by 15% year-over-year, driven by strong sales in the Asia-Pacific region [1]. - Net profit margin improved to 12%, up from 10% in the previous quarter [2]. - Operating expenses rose by 8%, primarily due to increased marketing and R&D investments [3]. Market Expansion - The company successfully entered two new markets in Europe, contributing to a 20% increase in international sales [4]. - A new distribution center was opened in South America to support regional growth [1]. - Strategic partnerships were formed with local retailers in Southeast Asia to enhance market penetration [3]. Product Development - Launched three new products in the tech segment, which accounted for 25% of total revenue [2]. - R&D spending increased by 10% to accelerate innovation and product differentiation [4]. - Customer feedback on the latest product line has been overwhelmingly positive, with a 95% satisfaction rate [1]. Operational Efficiency - Implemented new supply chain management software, reducing logistics costs by 5% [3]. - Streamlined manufacturing processes, resulting in a 7% reduction in production time [2]. - Enhanced inventory management systems, leading to a 10% decrease in stockouts [4]. Strategic Initiatives - Announced a new sustainability initiative aimed at reducing carbon emissions by 20% over the next five years [1]. - The company is exploring potential acquisitions to strengthen its market position in the healthcare sector [3]. - A new corporate governance framework was introduced to improve transparency and accountability [2]. Customer Engagement - Customer retention rates improved to 85%, up from 80% last year [4]. - Launched a loyalty program that has already attracted over 100,000 members [1]. - Enhanced customer service training programs resulted in a 15% increase in customer satisfaction scores [3].
Hologic (HOLX) is a Top-Ranked Value Stock: Should You Buy?
ZACKS· 2025-02-04 15:40
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are t ...
Countdown to Hologic (HOLX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
ZACKS· 2025-01-31 15:21
The upcoming report from Hologic (HOLX) is expected to reveal quarterly earnings of $1.02 per share, indicating an increase of 4.1% compared to the year-ago period. Analysts forecast revenues of $1.03 billion, representing an increase of 1.4% year over year.The consensus EPS estimate for the quarter has undergone a downward revision of 0.8% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timefra ...
Hologic (HOLX) Reports Next Week: Wall Street Expects Earnings Growth
ZACKS· 2025-01-29 16:06
Hologic (HOLX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on February 5. ...